Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GDI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC25A6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Homologene neighbors
MAPK14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZFR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDC27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OTULIN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPHB4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RETSAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCTN5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NEIL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAFB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DOCK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TCF25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF317 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPLL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREBL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZC3H7A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDX42 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATG5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on